Cybin (HELP) Cash from Investing Activities (2020 - 2025)

Cybin (HELP) reported Cash from Investing Activities of -$755457.5 for Q1 2025, down 373.48% on a YoY basis from $276238.9 in Q1 2024, and down 248.29% quarter-over-quarter from -$216902.3 in Q4 2024.

Cybin (HELP) Cash from Investing Activities (2020 - 2025) Analysis & Trends

Cybin has reported Cash from Investing Activities for 6 years, with the latest figure at -$755457.5 in Q1 2025.

  • For the quarter ending Q1 2025, Cash from Investing Activities fell 373.48% year-over-year to -$755457.5; the trailing twelve-month figure through Mar 2025 stood at -$1.4 million (down 127.49% YoY), and the FY2025 full-year result was -$1.4 million, down 127.53% from the prior year.
  • Cash from Investing Activities for Q1 2025 stood at -$755457.5, down from -$216902.3 in the prior quarter.
  • The five-year high for Cash from Investing Activities was $5.5 million in Q4 2023, with the low at -$2.1 million in Q1 2022.
  • Historically, Cash from Investing Activities has averaged $73314.5 across 5 years, with a median of -$166417.3 in 2024.
  • Annual changes were most pronounced in 2022 — Cash from Investing Activities sank 2835.02% — and 2023, when it soared 3693.26%.
  • Cybin's Cash from Investing Activities stood at -$131693.8 in 2021, then fell by 15.8% to -$152497.5 in 2022, then soared by 3693.26% to $5.5 million in 2023, then plunged by 103.96% to -$216902.3 in 2024, then slumped by 248.29% to -$755457.5 in 2025.
  • The last three Cash from Investing Activities figures came in at -$755457.5 (Q1 2025), -$216902.3 (Q4 2024), and -$250704.3 (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.89 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 638.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -431.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 579,519.10
10 Cybin 75.42 Mn 75.42 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2025 -755,457.46
Mar 31, 2025 -755,457.46
Dec 31, 2024 -216,902.29
Dec 31, 2024 -216,902.29
Sep 30, 2024 -250,704.27
Sep 30, 2024 -250,704.27
Jun 30, 2024 -173,280.31
Jun 30, 2024 -173,280.31
Mar 31, 2024 -159,554.34
Mar 31, 2024 -159,554.34
Dec 31, 2023 5.48 Mn
Dec 31, 2023 5.48 Mn
Sep 30, 2023 -192,450.06
Sep 30, 2023 -192,450.06
Jun 30, 2023 -48,389.41
Jun 30, 2023 -48,389.41
Feb 28, 2023 2.31 Mn
Feb 28, 2023 2.31 Mn
Dec 31, 2022 -152,497.51
Dec 31, 2022 -152,497.51